| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 7, Issue 3 397-404, Copyright © 1996 by American Association of Cancer Research
ARTICLES |
RK Singh, N Llansa, CD Bucana, R Sanchez, A Koura and IJ Fidler
Department of Cell Biology, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
We investigated some of the mechanisms that regulate the expression of basic fibroblast growth factor (bFGF) in human renal cell carcinoma (HRCC). HRCC SN12PM6 cells were cultured as adherent monolayers. The expression of steady-state bFGF mRNA (measured by in situ hybridization and Northern blot) and protein (measured by immunohistochemistry and ELISA) correlated inversely with the culture density. Tumor cells harvested from dense cultures (low bFGF expression) and plated under sparse conditions expressed high levels of bFGF mRNA and protein prior to cell division, suggesting that bFGF may be a competence factor. Similar data were obtained with human vascular endothelial cells. The expression of bFGF was not regulated by spent culture medium, cell cycle, or rate of cell division but was down-regulated by contract inhibition. These data show that the expression of bFGF in HRCC is cell density dependent.
This article has been cited by other articles:
![]() |
Y. Takemoto, H. Yano, S. Momosaki, S. Ogasawara, N. Nishida, S. Kojiro, T. Kamura, and M. Kojiro Antiproliferative Effects of Interferon-{alpha}Con1 on Ovarian Clear Cell Adenocarcinoma In vitro and In vivo Clin. Cancer Res., November 1, 2004; 10(21): 7418 - 7426. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Solorzano, R. Hwang, C. H. Baker, C. D. Bucana, P. W. Pisters, D. B. Evans, J. J. Killion, and I. J. Fidler Administration of Optimal Biological Dose and Schedule of Interferon {alpha} Combined with Gemcitabine Induces Apoptosis in Tumor-associated Endothelial Cells and Reduces Growth of Human Pancreatic Carcinoma Implanted Orthotopically in Nude Mice Clin. Cancer Res., May 1, 2003; 9(5): 1858 - 1867. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Morrish and M. G. Rumsby The 5' Untranslated Region of Protein Kinase C{delta} Directs Translation by an Internal Ribosome Entry Segment That Is Most Active in Densely Growing Cells and during Apoptosis Mol. Cell. Biol., September 1, 2002; 22(17): 6089 - 6099. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tedjarati, C. H. Baker, S. Apte, S. Huang, J. K. Wolf, J. J. Killion, and I. J. Fidler Synergistic Therapy of Human Ovarian Carcinoma Implanted Orthotopically in Nude Mice by Optimal Biological Dose of Pegylated Interferon {alpha} Combined with Paclitaxel Clin. Cancer Res., July 1, 2002; 8(7): 2413 - 2422. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jones, C. Fujiyama, C. Blanche, J. W. Moore, S. Fuggle, D. Cranston, R. Bicknell, and Adrian. L. Harris Relation of Vascular Endothelial Growth Factor Production to Expression and Regulation of Hypoxia-inducible Factor-1{{alpha}} and Hypoxia-inducible Factor-2{{alpha}} in Human Bladder Tumors and Cell Lines Clin. Cancer Res., May 1, 2001; 7(5): 1263 - 1272. [Abstract] [Full Text] |
||||
![]() |
J. I. Izawa and C. P.N. Dinney The role of angiogenesis in prostate and other urologic cancers: a review Can. Med. Assoc. J., March 1, 2001; 164(5): 662 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Fidler Regulation of Neoplastic Angiogenesis J Natl Cancer Inst Monographs, December 1, 2000; 2000(28): 10 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yano, H. Shinohara, R. S. Herbst, H. Kuniyasu, C. D. Bucana, L. M. Ellis, D. W. Davis, D. J. McConkey, and I. J. Fidler Expression of Vascular Endothelial Growth Factor Is Necessary but not Sufficient for Production and Growth of Brain Metastasis Cancer Res., September 1, 2000; 60(17): 4959 - 4967. [Abstract] [Full Text] |
||||
![]() |
A. D. Laird, P. Vajkoczy, L. K. Shawver, A. Thurnher, C. Liang, M. Mohammadi, J. Schlessinger, A. Ullrich, S. R. Hubbard, R. A. Blake, et al. SU6668 Is a Potent Antiangiogenic and Antitumor Agent That Induces Regression of Established Tumors Cancer Res., August 1, 2000; 60(15): 4152 - 4160. [Abstract] [Full Text] |
||||
![]() |
L. D. Ke, Y.-X. Shi, S.-A. Im, X. Chen, and W. K. A. Yung The Relevance of Cell Proliferation, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor Production to Angiogenesis and Tumorigenicity in Human Glioma Cell Lines Clin. Cancer Res., June 1, 2000; 6(6): 2562 - 2572. [Abstract] [Full Text] |
||||
![]() |
J. W. Slaton, P. Perrotte, K. Inoue, C. P. N. Dinney, and I. J. Fidler Interferon-{{alpha}}-mediated Down-Regulation of Angiogenesis-related Genes and Therapy of Bladder Cancer Are Dependent on Optimization of Biological Dose and Schedule Clin. Cancer Res., October 1, 1999; 5(10): 2726 - 2734. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Galy, A. Maret, A.-C. Prats, and H. Prats Cell Transformation Results in the Loss of the Density-dependent Translational Regulation of the Expression of Fibroblast Growth Factor 2 Isoforms Cancer Res., January 1, 1999; 59(1): 165 - 171. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |